nVerses Capital’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,574
Closed -$202K – 64
2026
Q2
$202K Buy
+5,574
New +$190K 0.31% 193
2024
Q3
– Sell
-1,700
Closed -$54.7K – 1066
2024
Q2
$54.7K Buy
1,700
+1,600
+1,600% +$55.5K 0.03% 579
2024
Q1
$3.88K Buy
+100
New +$3.5K 0.01% 600

Other funds holding COLL

nVerses Capital's COLL Position: Q3 2026 in Review

nVerses Capital sold out of Collegium Pharmaceutical (COLL) in Q3 2026, closing a stake of 5,574 shares — an estimated $202K sold.

nVerses Capital first reported a position in COLL in Q1 2024 and held it in 3 quarters. The position peaked at $202K in Q2 2026. 240 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • nVerses Capital reported no remaining Collegium Pharmaceutical position as of Q3 2026 after selling out during the quarter.
  • nVerses Capital sold 5,574 Collegium Pharmaceutical shares in Q3 2026, an estimated $202K.
  • nVerses Capital first reported a position in Collegium Pharmaceutical in Q1 2024 and held it in 3 quarters.
  • nVerses Capital's Collegium Pharmaceutical position peaked at $202K in Q2 2026.
  • 240 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on nVerses Capital's 13F filing for Q3 2026.